Clinical implications of mast cell-bacteria interaction

被引:36
|
作者
Malaviya, R [1 ]
Abraham, SN
机构
[1] Wayne Hughes Inst, Dept Allergy & Inflammatory Dis, St Paul, MN 55113 USA
[2] Duke Univ, Med Ctr, Dept Pathol & Microbiol, Durham, NC 27710 USA
来源
JOURNAL OF MOLECULAR MEDICINE-JMM | 1998年 / 76卷 / 09期
关键词
infection; inflammation; allergy; cytokines; innate immunity;
D O I
10.1007/s001090050259
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Mast cells are traditionally known for mediating allergic reactions. In addition, these cells have been implicated in the pathogenesis of a variety of clinical conditions such as atopic and contact dermatitis, bullous pemphigoid, fibrotic lung disease, neurofibromatosis, psoriasis, scleroderma, rheumatoid arthritis, interstitial cystitis, ulcerative colitis, and Crohn's disease, but their role in host defense was an enigma until recently. Owing to the strategic location of mast cells at the host environment interface, their role in bacterial infections has been studied by a number of investigators. Latest reports show that mast cells have an ability to modulate the host's innate immune response to infectious agents. This review discusses the clinical implications of mast cell-bacteria interactions.
引用
收藏
页码:617 / 623
页数:7
相关论文
共 50 条
  • [21] Colonic Mucosal Mast Cell Density in Patients with Diarrhea-Predominant Irritable Bowel Syndrome and Mast Cell Activation Syndrome: Implications for Clinical Practice
    Sepehr, G. J.
    Hamilton, M. J.
    Hornick, J. L.
    MODERN PATHOLOGY, 2014, 27 : 202A - 202A
  • [22] Colonic Mucosal Mast Cell Density in Patients with Diarrhea-Pedominant Irritable Bowel Syndrome and Mast Cell Activation Syndrome: Implications for Clinical Practice
    Sepehr, G. J.
    Hamilton, M. J.
    Hornick, J. L.
    LABORATORY INVESTIGATION, 2014, 94 : 202A - 202A
  • [23] Mast cell: an emerging partner in immune interaction
    Gri, Giorgia
    Frossi, Barbara
    D'Inca, Federica
    Danelli, Luca
    Betto, Elena
    Mion, Francesca
    Sibilano, Riccardo
    Pucillo, Carlo
    FRONTIERS IN IMMUNOLOGY, 2012, 3
  • [24] Clinical consequences of mast cell heterogeneity
    P. Forsythe
    M. Ennis
    Inflammation Research, 2000, 49 : 147 - 154
  • [25] Mast cell interaction with Trypanosoma cruzi.
    Leal-Berumen, I
    Pérez, AF
    Trillo, AL
    Martínez, FS
    FASEB JOURNAL, 2000, 14 (06): : A1127 - A1127
  • [26] Eosinophil-mast cell interaction: Mepolizumab leads to a reduction of clinical symptoms and serum tryptase in a patient with eosinophilic asthma and idiopathic mast cell activation
    Guillet, Carole
    Steinmann, Simona
    Lang, Claudia
    Maul, Julia-Tatjana
    Schmid-Grendelmeier, Peter
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (03): : 1393 - +
  • [27] Clinical consequences of mast cell heterogeneity
    Forsythe, P
    Ennis, M
    INFLAMMATION RESEARCH, 2000, 49 (04) : 147 - 154
  • [28] Mast Cell Sarcoma: Clinical Management
    Weiler, Catherine R.
    Butterfield, Joseph
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2014, 34 (02) : 423 - +
  • [29] Biological role and clinical implications of mast cells in surgery
    Dowdall, JF
    Winter, DC
    Baird, AW
    Bouchier-Hayes, D
    SURGERY, 2002, 132 (01) : 1 - 4
  • [30] Dermal Fibroblasts Control Mast Cell reactivity to commensal bacteria
    Chang, Yu-Ling
    Sriram, Krishna
    Wang, Zhenping
    Igawa, Satomi
    Wu, Chia-Chi
    Insel, Paul
    Di Nardo, Anna
    JOURNAL OF IMMUNOLOGY, 2019, 202 (01):